Backed by a team of dexterous professionals, we are engaged in offering a large number of perfect Repaglinide CAS 135062-02-1. Repaglinide is a potassium channel blocker, which can stimulate pancreas to release of insulin to decrease blood glucose. Repaglinide CAS NO 135062-02-1 is mainly application in treatment of type 2 diabetes. Customers can avail the Repaglinide 135062-02-1 as per their needs.
Thera. Category: Anti-Diabetes
Cas No.: 135062-02-1
Synonym: AG-EE-623;2-ETHOXY-4-[2-[(1S)-3-METHYL-1-[2-(1-PIPERIDINYL)BUTYL]AMINO]-2-OXOETHYL]-BENZOIC ACID;REPAGLINIDE;(S)-2-ETHOXY-4-(2-(3-METHYL-1-(2-(PIPERIDIN-1-YL)PHENYL)BUTYLAMINO)-2-OXOETHYL)BENZOIC ACID;(S)-(+)-2-ETHOXY-4-[N-[1-(2-PIPERIDINOPHENYL)-3-METHYL-1-BUTYL]AMINOCARBONYLMETHYL]BENZOIC ACID;NOVONORM;PRANDIN;ag-ee388zw
Molecular Formula: C27H36N2O4
Molecular Weight: 452.59
Assay: ≥99.%
Packing: Export worthy packing
lMaterial Safety Data Sheet: Available on request
Usage: Repaglinide is potent SUR1/Kir6.2 potassium channel blocker (Kd = 0.4 nM), which lowers blood glucose by stimulating the release of insulin from the pancreas, used the treatment of type II diabetes.